Literature DB >> 17674980

Radiotherapy adapted to spatial and temporal variability in tumor hypoxia.

Aste Søvik1, Eirik Malinen, Hege K Skogmo, Søren M Bentzen, Oyvind S Bruland, Dag Rune Olsen.   

Abstract

PURPOSE: To explore the feasibility and clinical potential of adapting radiotherapy to temporal and spatial variations in tumor oxygenation. METHODS AND MATERIALS: Repeated dynamic contrast enhanced magnetic resonance (DCEMR) images were taken of a canine sarcoma during the course of fractionated radiation therapy. The tumor contrast enhancement was assumed to represent the oxygen distribution. The IMRT plans were retrospectively adapted to the DCEMR images by employing tumor dose redistribution. Optimized nonuniform tumor dose distributions were calculated and compared with a uniform dose distribution delivering the same integral dose to the tumor. Clinical outcome was estimated from tumor control probability (TCP) and normal tissue complication probability (NTCP) modeling.
RESULTS: The biologically adapted treatment was found to give a substantial increase in TCP compared with conventional radiotherapy, even when only pretreatment images were used as basis for the treatment planning. The TCP was further increased by repeated replanning during the course of treatment, and replanning twice a week was found to give near optimal TCP. Random errors in patient positioning were found to give a small decrease in TCP, whereas systematic errors were found to reduce TCP substantially. NTCP for the adapted treatment was similar to or lower than for the conventional treatment, both for parallel and serial normal tissue structures.
CONCLUSION: Biologically adapted radiotherapy is estimated to improve treatment outcome of tumors having spatial and temporal variations in radiosensitivity.

Entities:  

Mesh:

Year:  2007        PMID: 17674980     DOI: 10.1016/j.ijrobp.2007.04.027

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management.

Authors:  Michael W Kissick; Xiaohu Mo; Keisha C McCall; Leah K Schubert; David C Westerly; Thomas R Mackie
Journal:  Phys Med Biol       Date:  2010-04-30       Impact factor: 3.609

2.  Molecular AFM imaging of Hsp70-1A association with dipalmitoyl phosphatidylserine reveals membrane blebbing in the presence of cholesterol.

Authors:  Constanze Lamprecht; Mathias Gehrmann; Josef Madl; Winfried Römer; Gabriele Multhoff; Andreas Ebner
Journal:  Cell Stress Chaperones       Date:  2018-02-05       Impact factor: 3.667

Review 3.  Personalized radiotherapy treatment planning based on functional imaging.

Authors:  Malgorzata Skórska; Tomasz Piotrowski
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-15

Review 4.  Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription.

Authors:  Søren M Bentzen; Vincent Gregoire
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

5.  Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: an exploratory study.

Authors:  Stephen R Bowen; Richard J Chappell; Søren M Bentzen; Michael A Deveau; Lisa J Forrest; Robert Jeraj
Journal:  Radiother Oncol       Date:  2012-06-08       Impact factor: 6.280

6.  On the sensitivity of IMRT dose optimization to the mathematical form of a biological imaging-based prescription function.

Authors:  Stephen R Bowen; Ryan T Flynn; Søren M Bentzen; Robert Jeraj
Journal:  Phys Med Biol       Date:  2009-02-13       Impact factor: 3.609

7.  Binding of heat shock protein 70 to extracellular phosphatidylserine promotes killing of normoxic and hypoxic tumor cells.

Authors:  Daniela Schilling; Mathias Gehrmann; Claudia Steinem; Antonio De Maio; Alan G Pockley; Michael Abend; Michael Molls; Gabriele Multhoff
Journal:  FASEB J       Date:  2009-03-16       Impact factor: 5.191

8.  A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Authors:  Stéphanie Servagi-Vernat; Sarah Differding; Francois-Xavier Hanin; Daniel Labar; Anne Bol; John A Lee; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

9.  Integrated transcriptomic response to cardiac chronic hypoxia: translation regulators and response to stress in cell survival.

Authors:  Dumitru A Iacobas; Chenhao Fan; Sanda Iacobas; Gabriel G Haddad
Journal:  Funct Integr Genomics       Date:  2008-05-01       Impact factor: 3.410

10.  Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.

Authors:  Hugo J W L Aerts; Angela A W van Baardwijk; Steven F Petit; Claudia Offermann; Judith van Loon; Ruud Houben; Anne-Marie C Dingemans; Rinus Wanders; Liesbeth Boersma; Jacques Borger; Gerben Bootsma; Wiel Geraedts; Cordula Pitz; Jean Simons; Bradly G Wouters; Michel Oellers; Philippe Lambin; Geert Bosmans; Andre L A J Dekker; Dirk De Ruysscher
Journal:  Radiother Oncol       Date:  2009-03-28       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.